121 related articles for article (PubMed ID: 37231583)
41. The effects of C-type natriuretic peptide on craniofacial skeletogenesis.
Nakao K; Okubo Y; Yasoda A; Koyama N; Osawa K; Isobe Y; Kondo E; Fujii T; Miura M; Nakao K; Bessho K
J Dent Res; 2013 Jan; 92(1):58-64. PubMed ID: 23114031
[TBL] [Abstract][Full Text] [Related]
42. A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells.
Li NF; Kocher HM; Salako MA; Obermueller E; Sandle J; Balkwill F
Oncogene; 2009 Feb; 28(5):773-80. PubMed ID: 18997822
[TBL] [Abstract][Full Text] [Related]
43. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
[TBL] [Abstract][Full Text] [Related]
44. Osteoclast activity sculpts craniofacial form to permit sensorineural patterning in the zebrafish skull.
Miao KZ; Cozzone A; Caetano-Lopes J; Harris MP; Fisher S
Front Endocrinol (Lausanne); 2022; 13():969481. PubMed ID: 36387889
[TBL] [Abstract][Full Text] [Related]
45. Postnatal Ontogeny of the Cranial Base and Craniofacial Skeleton in Male C57BL/6J Mice: A Reference Standard for Quantitative Analysis.
Vora SR; Camci ED; Cox TC
Front Physiol; 2015; 6():417. PubMed ID: 26793119
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus.
Rojo R; Pridans C; Langlais D; Hume DA
Clin Sci (Lond); 2017 Aug; 131(16):2161-2182. PubMed ID: 28760770
[TBL] [Abstract][Full Text] [Related]
47. Production and characterisation of a monoclonal antibody that recognises the chicken CSF1 receptor and confirms that expression is restricted to macrophage-lineage cells.
Garcia-Morales C; Rothwell L; Moffat L; Garceau V; Balic A; Sang HM; Kaiser P; Hume DA
Dev Comp Immunol; 2014 Feb; 42(2):278-85. PubMed ID: 24084378
[TBL] [Abstract][Full Text] [Related]
48. A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.
Aarhus TI; Eickhoff J; Klebl B; Unger A; Boros J; Choidas A; Zischinsky ML; Wolowczyk C; Bjørkøy G; Sundby E; Hoff BH
Eur J Med Chem; 2023 Jul; 255():115344. PubMed ID: 37141705
[TBL] [Abstract][Full Text] [Related]
49. Flrt2 and Flrt3 have overlapping and non-overlapping expression during craniofacial development.
Gong SG; Mai S; Chung K; Wei K
Gene Expr Patterns; 2009 Oct; 9(7):497-502. PubMed ID: 19635589
[TBL] [Abstract][Full Text] [Related]
50. JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor.
Uesato N; Inagaki K; Miyagawa N; Kitagawa Y; Kakefuda R; Matsuo Y; Yamaguchi T; Hata T; Ikegashira K; Matsushita M
Biol Pharm Bull; 2020; 43(12):1884-1892. PubMed ID: 33268706
[TBL] [Abstract][Full Text] [Related]
51. Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors.
Liang X; Wang C; Wang B; Liu J; Qi S; Wang A; Liu Q; Deng M; Wang L; Liu J; Liu Q
Eur J Med Chem; 2022 Dec; 243():114782. PubMed ID: 36179404
[TBL] [Abstract][Full Text] [Related]
52. Pax6 regulates craniofacial form through its control of an essential cephalic ectodermal patterning center.
Compagnucci C; Fish JL; Schwark M; Tarabykin V; Depew MJ
Genesis; 2011 Apr; 49(4):307-25. PubMed ID: 21309073
[TBL] [Abstract][Full Text] [Related]
53. Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.
Yang Y; Ishima T; Wan X; Wei Y; Chang L; Zhang J; Qu Y; Hashimoto K
Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):483-495. PubMed ID: 34480631
[TBL] [Abstract][Full Text] [Related]
54. Functional evolution of the colony-stimulating factor 1 receptor (CSF1R) and its ligands in birds.
Hume DA; Gutowska-Ding MW; Garcia-Morales C; Kebede A; Bamidele O; Trujillo AV; Gheyas AA; Smith J
J Leukoc Biol; 2020 Feb; 107(2):237-250. PubMed ID: 31487076
[TBL] [Abstract][Full Text] [Related]
55. Variability of the cranial and dental phenotype in Williams syndrome.
Axelsson S
Swed Dent J Suppl; 2005; (170):3-67. PubMed ID: 15762376
[TBL] [Abstract][Full Text] [Related]
56.
Hawley CA; Rojo R; Raper A; Sauter KA; Lisowski ZM; Grabert K; Bain CC; Davis GM; Louwe PA; Ostrowski MC; Hume DA; Pridans C; Jenkins SJ
J Immunol; 2018 Mar; 200(6):2209-2223. PubMed ID: 29440354
[TBL] [Abstract][Full Text] [Related]
57. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.
Luo J; Elwood F; Britschgi M; Villeda S; Zhang H; Ding Z; Zhu L; Alabsi H; Getachew R; Narasimhan R; Wabl R; Fainberg N; James ML; Wong G; Relton J; Gambhir SS; Pollard JW; Wyss-Coray T
J Exp Med; 2013 Jan; 210(1):157-72. PubMed ID: 23296467
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
59. Osteoblastic RAR Inhibition Causes VAD-Like Craniofacial Skeletal Deformity.
Dai Q; Sun S; Jin A; Gong X; Xu H; Yang Y; Huang X; Wang X; Liu Y; Gao J; Gao X; Liu J; Bian Q; Wu Y; Jiang L
J Dent Res; 2023 Jun; 102(6):667-677. PubMed ID: 37036085
[TBL] [Abstract][Full Text] [Related]
60. A dysmorphic mouse model reveals developmental interactions of chondrocranium and dermatocranium.
Motch Perrine SM; Pitirri MK; Durham EL; Kawasaki M; Zheng H; Chen DZ; Kawasaki K; Richtsmeier JT
Elife; 2022 Jun; 11():. PubMed ID: 35704354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
